Found: 7
Select item for more details and to access through your institution.
Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.
- Published in:
- BioScience Trends, 2017, v. 11, n. 2, p. 214, doi. 10.5582/bst.2016.01228
- By:
- Publication type:
- Article
CdS nanoflakes decorated by Ni(OH)<sub>2</sub> nanoparticles for enhanced photocatalytic hydrogen production.
- Published in:
- International Journal of Energy Research, 2021, v. 45, n. 10, p. 14985, doi. 10.1002/er.6777
- By:
- Publication type:
- Article
The Histone Acetyltransferase MOF Regulates SIRT1 Expression to Suppress Renal Cell Carcinoma Progression.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.842967
- By:
- Publication type:
- Article
Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
- Published in:
- FASEB Journal, 2018, v. 32, p. 73, doi. 10.1096/fj.201700418R
- By:
- Publication type:
- Article
Switching of the substrate specificity of protein tyrosine phosphatase N12 by cyclin-dependent kinase 2 phosphorylation orchestrating 2 oncogenic pathways.
- Published in:
- FASEB Journal, 2018, v. 32, n. 1, p. 73, doi. 10.1096/fj.201700418R
- By:
- Publication type:
- Article
LncRNA RCAT1 promotes tumor progression and metastasis via miR-214-5p/E2F2 axis in renal cell carcinoma.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 7, p. 1, doi. 10.1038/s41419-021-03955-7
- By:
- Publication type:
- Article
A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 5, p. 1, doi. 10.1038/s41419-018-0582-1
- By:
- Publication type:
- Article